Your browser doesn't support javascript.
COVID-19 drug practices risk antimicrobial resistance evolution.
Afshinnekoo, Ebrahim; Bhattacharya, Chandrima; Burguete-García, Ana; Castro-Nallar, Eduardo; Deng, Youping; Desnues, Christelle; Dias-Neto, Emmanuel; Elhaik, Eran; Iraola, Gregorio; Jang, Soojin; Labaj, Pawel P; Mason, Christopher E; Nagarajan, Niranjan; Poulsen, Michael; Prithiviraj, Bharath; Siam, Rania; Shi, Tieliu; Suzuki, Haruo; Werner, Johannes; Zambrano, Maria Mercedes; Bhattacharyya, Malay.
  • Afshinnekoo E; Department of Physiology and Biophysics, Weill Cornell Medicine, New York, USA.
  • Bhattacharya C; The HRH Prince Alwaleed Bin Talal Bin Abdulaziz Alsaud Institute for Computational Biomedicine, Weill Cornell Medicine, New York, USA.
  • Burguete-García A; Department of Physiology and Biophysics, Weill Cornell Medicine, New York, USA.
  • Castro-Nallar E; The HRH Prince Alwaleed Bin Talal Bin Abdulaziz Alsaud Institute for Computational Biomedicine, Weill Cornell Medicine, New York, USA.
  • Deng Y; Center for Research on Infectious Diseases, National Institute of Public Health, Cuernavaca, Mexico.
  • Desnues C; Center for Bioinformatics and Integrative Biology, Universidad Andres Bello, Santiago, Chile.
  • Dias-Neto E; Department of Quantitative Health Sciences, John A Burns School of Medicine, University of Hawaii at Manoa, Honolulu, USA.
  • Elhaik E; Aix-Marseille University, University of Toulon, National Center for Scientific Research, French National Research Institute for Sustainable Development, Mediterranean Institute of Oceanography, Marseille, France.
  • Iraola G; Medical Genomics Group, A C Camargo Cancer Center and LIM-27, Institute of Psychiatry, Faculdade de Medicina, Universidade de São Paulo, São Paulo, Brazil.
  • Jang S; Department of Biology, Lund University, Lund, Sweden.
  • Labaj PP; Microbial Genomics Laboratory, Institut Pasteur Montevideo, Montevideo, Uruguay.
  • Mason CE; Discovery of Biology, Antibacterial Resistance Laboratory, Institut Pasteur Korea, Seongnam, South Korea.
  • Nagarajan N; Malopolska Centre of Biotechnology, Jagiellonian University, Krakow, Poland.
  • Poulsen M; Department of Physiology and Biophysics, Weill Cornell Medicine, New York, USA.
  • Prithiviraj B; The HRH Prince Alwaleed Bin Talal Bin Abdulaziz Alsaud Institute for Computational Biomedicine, Weill Cornell Medicine, New York, USA.
  • Siam R; WorldQuant Initiative for Quantitative Prediction, Weill Cornell Medicine, New York, USA.
  • Shi T; Genome Institute of Singapore, ASTAR and Yong Loo Lin School of Medicine, National University of Singapore, Singapore.
  • Suzuki H; Section for Ecology and Evolution, Department of Biology, University of Copenhagen, Copenhagen, Denmark.
  • Werner J; Department of Biology, Brooklyn College of the City University of New York, New York, USA.
  • Zambrano MM; University of Medicine and Health Sciences, Basettere, St Kitts and Nevis.
  • Bhattacharyya M; Biology Department, The American University in Cairo, Cairo, Egypt.
Lancet Microbe ; 2(4): e135-e136, 2021 04.
Article in English | MEDLINE | ID: covidwho-1101597
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Drug Treatment Type of study: Prognostic study Limits: Humans Language: English Journal: Lancet Microbe Year: 2021 Document Type: Article Affiliation country: S2666-5247(21)00039-2

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Drug Treatment Type of study: Prognostic study Limits: Humans Language: English Journal: Lancet Microbe Year: 2021 Document Type: Article Affiliation country: S2666-5247(21)00039-2